View in EDS HTML Full Text PDF Full Text

Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.

Saved in:
Bibliographic Details
Title: Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Authors: Hughes, Brett G. M.1,2 (AUTHOR) brett.hughes@health.qld.gov.au, Mendoza, Rene Gonzalez3 (AUTHOR), Basset-Seguin, Nicole4 (AUTHOR), Vornicova, Olga5 (AUTHOR), Schachter, Jacob6 (AUTHOR), Joshi, Abhishek7 (AUTHOR), Meyer, Nicolas8 (AUTHOR), Grange, Florent9,10 (AUTHOR), Piulats, Josep M.11 (AUTHOR), Bauman, Jessica R.12 (AUTHOR), Chirovsky, Diana13 (AUTHOR), Zhang, Pingye13 (AUTHOR), Gumuscu, Burak13 (AUTHOR), Swaby, Ramona F.13 (AUTHOR), Grob, Jean-Jacques14 (AUTHOR)
Source: Dermatology & Therapy. Oct2021, Vol. 11 Issue 5, p1777-1790. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-021-00598-6